Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Change in Accured Expenses (2020 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Change in Accured Expenses for 6 consecutive years, with $17.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses rose 169.33% year-over-year to $17.4 million, compared with a TTM value of $12.0 million through Sep 2025, up 244.46%, and an annual FY2024 reading of $6.4 million, down 72.35% over the prior year.
  • Change in Accured Expenses was $17.4 million for Q3 2025 at Aveanna Healthcare Holdings, up from $6.1 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $18.1 million in Q3 2023 and bottomed at -$8.4 million in Q4 2023.
  • Average Change in Accured Expenses over 5 years is $2.2 million, with a median of $131500.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses tumbled 515.94% in 2021, then skyrocketed 556.52% in 2023.
  • Year by year, Change in Accured Expenses stood at -$7.6 million in 2021, then soared by 79.86% to -$1.5 million in 2022, then tumbled by 450.85% to -$8.4 million in 2023, then skyrocketed by 35.09% to -$5.5 million in 2024, then soared by 417.77% to $17.4 million in 2025.
  • Business Quant data shows Change in Accured Expenses for AVAH at $17.4 million in Q3 2025, $6.1 million in Q2 2025, and -$6.0 million in Q1 2025.